Phase II study of autism co-morbid for attention deficit hyperactivity disorder.

Trial Profile

Phase II study of autism co-morbid for attention deficit hyperactivity disorder.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Apr 2014

At a glance

  • Drugs Methylphenidate (Primary)
  • Indications Attention-deficit hyperactivity disorder; Autistic disorder
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Sep 2010 Trial phase changed from II to III as reported by ClinicalTrials.gov.
    • 21 Aug 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
    • 21 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top